Wealth Enhancement Advisory Services’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$225K Sell
11,101
-101,200
-90% -$2.54M ﹤0.01% 3634
2026
Q2
$3.33M Buy
112,301
+780
+0.7% +$24.8K 0.01% 1250
2026
Q1
$3.66M Buy
+111,521
New +$3.51M 0.01% 1060
2024
Q3
– Sell
-7,289
Closed -$216K – 2903
2024
Q2
$216K Buy
+7,289
New +$202K ﹤0.01% 2233

Other funds holding RTO

Wealth Enhancement Advisory Services's RTO Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Rentokil (RTO) stake by 90% in Q3 2026, selling an estimated $2.54M and leaving 11,101 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #3634.

Wealth Enhancement Advisory Services first reported a position in RTO in Q2 2024 and has held it in 4 quarters since. The position peaked at $3.66M in Q1 2026. 113 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Wealth Enhancement Advisory Services held 11,101 shares of Rentokil worth $225K as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 101,200 Rentokil shares in Q3 2026, an estimated $2.54M.
  • Rentokil made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3634 holding.
  • Wealth Enhancement Advisory Services first reported a position in Rentokil in Q2 2024 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's Rentokil position peaked at $3.66M in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.